OBA-PHARMA ApS: Financial statements 2019
CVR: 19995607
Source: annual report 2019, Danish Business Authority
01/10/2018 – 30/09/2019
OBA-PHARMA ApS (CVR 19995607) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,252,532 and a net result of DKK 1,803,661 compared with DKK 2,069,878 the year before. That is a decrease of 10.7% compared with the year before. Equity in the 2019 report amounted to DKK 2,302,083. The solvency ratio was 51.7%.
- Gross Profit
- DKK 2,252,532
- Profit/Loss
- DKK 1,803,661
- Equity
- DKK 2,302,083
- Total Assets
- DKK 4,455,931
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 2.3 mio. | 1.8 mio. | 2.3 mio. | - |
| 2018 | - | 2.5 mio. | 2.1 mio. | 6.5 mio. | - |
| 2017 | - | 2.8 mio. | 2.2 mio. | 4.4 mio. | - |
| 2016 | - | 2.8 mio. | 2.2 mio. | 2.8 mio. | - |
| 2015 | - | 3.2 mio. | 2.5 mio. | 3.1 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
OBA-PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 2,521,605, and the net result was DKK 2,069,878.
About OBA-PHARMA ApS
OBA-PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PBH 25.376 ApS. The management consists of Malene Dybdahl Birch. The company is owned by LEV-VEL ApS and NLDB Holding ApS. The company has 0 employees (2000). In 2024, the company reported a gross profit of DKK 3,402,201 and a net result of DKK 2,670,973 compared with DKK 2,073,440 the year before. Equity in the 2024 report amounted to DKK 674,251.